Favorable fetal outcome in a high-risk Rh-alloimmunized pregnancy with high indirect coombs titre complicated by systemic sclerosis: a rare case report

Authors

  • Riddhi T. Shah Department of Obstetrics and Gynecology, GCS Medical College Hospital and Research Centre, Ahmedabad, Gujarat, India
  • Chanchal Kriplani Department of Obstetrics and Gynecology, GCS Medical College Hospital and Research Centre, Ahmedabad, Gujarat, India
  • Pooja Singh Department of Obstetrics and Gynecology, GCS Medical College Hospital and Research Centre, Ahmedabad, Gujarat, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20263068

Keywords:

Rh alloimmunization, Diffuse systemic sclerosis, Indirect Coombs test, High-risk pregnancy, Neonatal hyperbilirubinemia, Case report

Abstract

Rh alloimmunization remains an important cause of fetal and neonatal morbidity despite anti-D prophylaxis. Pregnancy in diffuse systemic sclerosis is uncommon and associated with significant maternal and fetal risks. The coexistence of these two high-risk conditions is rare. Case Presentation: 25-year-old G2P1D1 with diffuse systemic sclerosis and Rh-negative blood group was managed with serial antenatal surveillance. Indirect Coombs titres progressively increased from 1:256 at 32 weeks to 1:512 at 34 weeks. Serial ultrasonography showed no evidence of hydrops fetalis and until delivery, fetal surveillance findings remained reassuring, with reactive third-trimester non-stress tests. Elective cesarean section was performed at 34+2 weeks for severe Rh alloimmunization with breech presentation. A healthy male neonate weighing 2.5 kg was delivered and managed successfully with phototherapy for neonatal hyperbilirubinemia. Conclusion: Favorable outcomes can be achieved through multidisciplinary care, close surveillance, and timely delivery.

References

Cunningham FG, Leveno KJ, Bloom SL, Dashe JS, Hoffman BL, Casey BM. Williams Obstetrics. 27th ed. New York: McGraw-Hill Education; 2022.

Royal College of Obstetricians and Gynaecologists. The management of women with red cell antibodies during pregnancy. Green-top Guideline No. 65. London: RCOG; 2014.

Moise KJ Jr. Management of rhesus alloimmunization in pregnancy. Obstet Gynecol. 2008;112(1):164-76.

Hughes M, Herrick AL. Systemic sclerosis and pregnancy. Rheumatology (Oxford). 2020;59(Suppl 5):v46-v55.

Taraborelli M, Ramoni V, Brucato A, Airò P, Bajocchi G, Bellisai F, et al. Brief report: successful pregnancies but a higher risk of preterm births in patients with systemic sclerosis: an Italian multicenter study. Arthritis Rheumatol. 2012;64(6):1970-7.

Denton CP, Khanna D. Systemic sclerosis. Lancet. 2017;390(10103):1685-99.

Oepkes D, Seaward PG, Vandenbussche FPHA, Windrim R, Kingdom J, Beyene J, et al. Doppler ultrasonography versus amniocentesis to predict fetal anemia. N Engl J Med. 2006;355(2):156-64.

Downloads

Published

2026-08-27

How to Cite

Shah, R. T., Kriplani, C., & Singh, P. (2026). Favorable fetal outcome in a high-risk Rh-alloimmunized pregnancy with high indirect coombs titre complicated by systemic sclerosis: a rare case report . International Journal of Reproduction, Contraception, Obstetrics and Gynecology, 15(9), 3711–3714. https://doi.org/10.18203/2320-1770.ijrcog20263068

Issue

Section

Case Reports